-
Towards novel therapies of iTTP: Defining and shielding of antibody epitopes on ADAMTS13
Postmus, H. T., 2026, 206 p.Research output: PhD Thesis › PhD-Thesis - Research and graduation internal
-
Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP
Postmus, T., Jansen, R., Kaijen, P., van Alphen, F., van der Zwaan, C., Hoogendijk, A. J., Coppo, P., Joly, B. R. S., Veyradier, A., Vanhoorelbeke, K., Nicolaes, G. & Voorberg, J., 28 Oct 2025, In: Blood. 9, 20, p. 5350-5361 12 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP
Postmus, T., Schilder, N., de Santana, J. F., Langerhorst, P., Kaijen, P., Coppo, P., Joly, B. R. S., Veyradier, A., Vanhoorelbeke, K. & Voorberg, J., 8 Apr 2025, In: Blood. 9, 7, p. 1728-1737 10 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
